Promega Corporation

Cell-Based Bioluminescent Assays for Proteasome Activity Scientific Poster

Share

SEARCH POSTERS

Abstract

Richard Moravec, Martha O'Brien, Tracy Worzella, Bill Daily*, Mike Scurria*, Laurent Bernad*, Kay Rashka, Jeri Culp, Sandra Hagen, Brian McNamara, Alyssa TenHarmsel and Terry Riss
Promega Corporation, 2800 Woods Hollow Rd., Madison, WI 53711
*Promega Biosciences Inc., 277 Granada Dr., San Luis Obispo, CA 93401

We have developed a series of cell-based assays that individually measure the chymotrypsin-like, trypsin-like or caspase-like activities of the proteasome. Each assay utilizes a specific luminogenic proteasome peptide substrate in a buffer optimized for cell permeabilization, proteasome activity and luciferase activity. Addition of the reagent directly to cultured cells gently permeabilizes cellular plasma membranes, allowing substrate and reagent access to the cytosolic proteasome. Luminescence is generated in a coupled enzyme format, as proteasome cleavage of the peptide substrate generates aminoluciferin, which is a substrate for luciferase. A stable glow-type luminescent signal is obtained 10-15 minutes after addition of reagent. Luminogenic proteasome substrates enabled development of the "add-mix-measure" assays with adequate sensitivity to be miniaturized into 96 and 384-well plate formats.

Document Icon Download the poster PDF (94kb)

  • Part# PS069
  • Printed in USA.

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.

Scientists at Your Service

Scientists at Your Service

We offer a range of services to help you succeed using Promega technologies. From product training to set up of automated systems and development of custom applications—our scientific support goes beyond the basics.

Ask us! We are here to help you.